Not a member? Sign Up

Reasons for Joining

    Address your challenges through knowledge sharing with peers from our global network of specialists.

    Benchmark your business initiatives with the who's who in the field.

    Hear from industry pioneers how to maximize ROI in today's challenging economy.

    And best of all It's FREE!
Sign in using your existing
Pharma IQ account
Username or Email:

Sign Up  |  Already a member? Sign In  |  Visit IQPC.com  
Pharma IQ

How Can Polymorph Patents Increase Cost Efficiency?

Contributor:  Pharma IQ News
Posted:  10/13/2010  12:00:00 AM EDT  | 
0

Rate this Article: (3.0 Stars | 12 Votes)

Pharma IQ have just made a great new podcast interview available on the Resource Centre; How can polymorph patents increase cost efficiency?

The podcast is an interview with Mandar Kodgule, Head of Intellectual Property and Strategic planning at Wockhardt and is available on the Developing IP Strategies for Crystalline Forms website, completely FREE of charge.

Kodgule answers the above question as well as offering the top five strategic considerations to sustain a healthy polymorph patent portfolio and to create polymorphic wealth. The interview also touches upon how the regulatory landscape is changing and what impact it is having on enforceability of polymorph patents. Mandar also addresses the issue of excessive innovation in the polymorph arena, which is leading to misuse in certain cases, and why this is so.

For those wishing to hear more on this subject, Mandar will do a session on; Balance Sheet For Polymorph Patents: Creation, Enforceability, Misuse & Challenges at the Developing IP Strategies for Crystalline Forms Conference, which runs from 6th-8th December 2010 in London.

Wockhardt, Bayer Healthcare, Alembic, European Patent Office and Hovione are just a few of the companies who will be coming together to share IP and patent protection best practice and work together to find the optimum way to prevent patent infringement of their companies’ crystalline forms.

From interactive panel sessions and insights into both innovator and generic perspectives to updates on case law decisions from around the world, senior IP Counsel from across the globe will be presenting their areas of expertise, learning from one another and sharing tips at the 6th Annual Developing IP Strategies for Crystalline Forms. 

---Ends---

Editors Notes. IQPC has an established reputation for delivering the highest standard of industry specific conferences, seminars and internal training programmes. We aim to keep business executives up-to date with the forefront of their industries’ trends, technological developments and regulatory landscape.

For any more information please contact: Viktoria Strandlund, +44 (0)20 7368 9300, viktoria.strandlund@iqpc.co.uk or visit http://www.ipcrys.com/.

[eventpdf]



Pharma IQ News Contributor:   Pharma IQ News


* = required.

Not a member yet? Sign up
User Name:
Password:

Be the first to leave a comment
Sign in or Sign up to post a comment

Advertisement

Events of Interest
Download Brochure

Please complete the information below to complete your download.

Please note: That all fields marked with an asterisk (*) are required.

First Name *
Last Name *
Job Title *
Company Name *
Email Address *
Telephone *
Country *
Where did you hear about us? *

I would like to receive information about sponsorship and exhibition opportunities

Yes, sign me up for the FREE Pharma IQ e-newsletter, including information on FREE Podcasts, Webinars, event discounts and online learning opportunities.

Advertisement